Malignant hyperthermia due to anaesthesia (Q49249): Difference between revisions

← Older edit

@@ Property / CURIE @@
+CID11:NE86
@@ Property / CURIE: CID11:NE86 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-NE86
@@ Property / Canary Token: dki-india-NE86 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+T88.3
@@ Property / Linked ICD 10: T88.3 / rank @@
+Normal rank

Latest revision as of 19:37, 13 August 2026

A condition caused by hypermetabolism in response to certain anaesthetic drugs. This condition is characterised by hyperthermia, tachycardia, tachypnoea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity, and rhabdomyolysis. This condition may be associated with genetic mutation.

Language	Label	Description	Also known as
default for all languages	NE86
English	Malignant hyperthermia due to anaesthesia	A condition caused by hypermetabolism in response to certain anaesthetic drugs. This condition is characterised by hyperthermia, tachycardia, tachypnoea, increased carbon dioxide production, increased oxygen consumption, acidosis, muscle rigidity, and rhabdomyolysis. This condition may be associated with genetic mutation.